Both in Biotechnology
Recursion Pharmaceuticals vs BioCryst Pharmaceuticals
Over the past year RXRX returned −17.9% and BCRX returned +9.5%; their daily moves had a correlation of 0.21.
RXRX −17.9% BCRX +9.5%Growth of $1, one year, split-adjusted
| Metric | RXRX | BCRX |
|---|---|---|
| Price | $4.03 | $8.27 |
| Market cap | $2.16B | $2.11B |
| Today | +8.92% | −2.36% |
| 1 month | +20.7% | −15.8% |
| 6 months | +41.9% | −12.5% |
| Year to date | −1.5% | +6.0% |
| 1 year | −14.6% | +8.4% |
| Revenue growth (YoY) | −60.1% | +33.6% |
| Gross margin | −49.8% | 98.2% |
| Net margin | −1708.0% | 35.9% |
| P/E (TTM) | — | — |
| Price / sales | 39.4× | 2.2× |
| Net cash | $531.5M | -$471.6M |
| Dividend yield | — | — |
| Volatility (60d) | 74.2% | 48.0% |
| Short % of float | 41.4% | 17.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).